Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bt7
    Junior Member
    • Aug 2011
    • 1

    #1

    RPKM normalization between samples

    I have 8 RNA-seq datasets comprising 4 biological replicates for 2 treatments (control and condition). From what I understand, the samples were run in a 4-plex format such that each Illumina run contained one biological rep from each of the 2 treatments. So, none of the biological reps were run together. The reads have already been mapped to an EST database and I now have RPKM values for all of the genes in each of the 8 samples.

    1. RPKM values are normalized for comparison of genes within a sample, but can RPKM values be compared between samples (treatment vs. control, in my case) within an Illumina run? And can RPKM values be compared between samples (biological replicates, in my case) in separate Illumina runs? If not, what is the best method of normalization?

    2. How do I go about determining which genes are differentially expressed between the control and treatment, using the RPKM values?

    Any info for someone new to RNA-seq analysis would be much appreciated.

    Thanks!
  • d17
    Member
    • Sep 2008
    • 27

    #2
    Take a look at the DESeq or edgeR packages. Both of these will take raw counts (not RPKM) and perform statistical tests for differential expression between control and condition.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:13 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Working...